A biotechnology visionary, Carsten Thiel is a highly valued leader for his ability to lead through a highly experienced lens. It is fair to say that Thiel has had a lot to do with making a major impact in whatever projects he’s had the pleasure of being involved in, including launching such high-profile projects in the medical field as Prolia, Strensiq, Neulasta, and Vectibix.
Each of these products have done so much to improve the quality of life of many patients. Neulasta, for example, is a white blood cell booster that is often prescribed to cancer patients going through therapy. Strensiq, on the other hand, is a highly innovative medicine that is the only one of its kind to help treat those with the rare condition of hypophosphatasia. Combining ethics with his work, Carsten Thiel has spearheaded campaigns that have made these medicines possible.
An impressive student while he was growing up, Carsten Thiel has always shown educational excellence and a keen talent in the field of medicine development. A star chemist right from the start, Carsten Thiel attended Marburg, where he graduated only to continue on with even more education in the field he was most interested in at University of Bristol.
At first, it was all about organic chemistry, which eventually turned into a study of biochemistry, concentrating squarely on that once he received his Bachelor of Science degree. As a final stop in his educational journey towards ultimate understanding in the field of biochemistry, Thiel completed his courses at Max Planck Institute for Biophysical Chemistry. This was where he graduated and received his PhD in Molecular Biology.
From there onward, Thiel found great success in the field of pharmaceuticals, which eventually landed him a starting position at a biotechnology firm with Hoffman La-Roche. Initially his title was Communications and Product Manager and from there his career took off, to the point that he became who he is now today as a highly respected biochemist in his field.
Carsten Thiel’s: Twitter.